Medical Journals

Hyposmotic Challenge Inhibits Inward Rectifying K+ Channels in Cerebral Arterial Smooth Muscle Cells.

Authors:
  • Wu Bin-Nan
  • Luykenaar Kevin D
  • Brayden Joseph E
  • Giles Wayne R
  • Corteling Randolph L
  • Wiehler William B
  • Welsh Donald G

From: Department and Graduate Institute of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Feb 2007
  • ISSN: 0363-6135
  • Volume: 292
  • Issue: 2
  • Pages: H1085-94
  • Medium: Print
  • Language: English
  • Citation (JAMA): Wu Bin-Nan, Luykenaar Kevin D, Brayden Joseph E, et al. Hyposmotic Challenge Inhibits Inward Rectifying K+ Channels in Cerebral Arterial Smooth Muscle Cells.. Am. J. Physiol. Heart Circ. Physiol. Feb 2007;292:H1085-94

Abstract

This study sought to define whether inward rectifying K(+) (K(IR)) channels were modulated by vasoactive stimuli known to depolarize and constrict intact cerebral arteries. Using pressure myography and patch-clamp electrophysiology, initial experiments revealed a Ba(2+)-sensitive K(IR) current in cerebral arterial smooth muscle cells that was active over a physiological range of membrane potentials and whose inhibition led to arterial depolarization and constriction. Real-time PCR, Western blot, and immunohistochemical analyses established the expression of both K(IR)2.1 and K(IR)2.2 in cerebral arterial smooth muscle cells. Vasoconstrictor agonists known to depolarize and constrict rat cerebral arteries, including uridine triphosphate, U46619, and 5-HT, had no discernable effect on whole cell K(IR) activity. Control experiments confirmed that vasoconstrictor agonists could inhibit the voltage-dependent delayed rectifier K(+) (K(DR)) current. In contrast to these observations, a hyposmotic challenge that activates mechanosensitive ion channels elicited a rapid and sustained inhibition of the K(IR) but not the K(DR) current. The hyposmotic-induced inhibition of K(IR) was 1) mimicked by phorbol-12-myristate-13-acetate, a PKC agonist; and 2) inhibited by calphostin C, a PKC inhibitor. These findings suggest that, by modulating PKC, mechanical stimuli can regulate K(IR) activity and consequently the electrical and mechanical state of intact cerebral arteries. We propose that the mechanoregulation of K(IR) channels plays a role in the development of myogenic tone.

Mesh Headings (Keywords): 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, Animals, Cerebral Arteries, Female, Hypotonic Solutions, Membrane Potentials, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Naphthalenes, Patch-Clamp Techniques, Potassium Channels, Inwardly Rectifying, Protein Kinase C, Protein Kinase Inhibitors, RNA, Messenger, Rats, Rats, Sprague-Dawley, Serotonin, Tetradecanoylphorbol Acetate, Uridine Triphosphate, Vasoconstrictor Agents


Check for Full Text / PubMed Unique Identifier (PMID): 17056667


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.